Newsroom
Category
November 10, 2022
During Diabetes Awareness Month (November), UT Health San Antonio endocrinologist Carolina Solis-Herrera, MD, reminds the community that one in every three people in San Antonio has prediabetes, which physicians define by a hemoglobin A1C percentage of 5.7% to 6.4%. Hemoglobin A1C is a blood test that measures average glucose levels over the past three months. Carolina […]
November 1, 2022
The NIA Interventions Testing Program, including UT Health San Antonio, collaborated with peers in Tennessee and Switzerland. Researchers from the National Institute on Aging (NIA)-funded Interventions Testing Program recently reported the discovery of multiple candidate genes that influence longevity. The three Interventions Testing Program sites – UT Health San Antonio, The University of Michigan […]
October 13, 2022
The Podiatric Medicine and Surgery Residency Program at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) celebrates its 50th anniversary in 2022. The program, which includes its clinical partner, University Health in San Antonio and its affiliated clinic, the Texas Diabetes Institute, is one of the oldest programs in […]
October 10, 2022
Eating cold-water fish and other sources of omega-3 fatty acids may preserve brain health and enhance cognition in middle age, new evidence indicates. Having at least some omega-3s in red blood cells was associated with better brain structure and cognitive function among healthy study volunteers in their 40s and 50s.
October 7, 2022
Researchers from UT Health San Antonio are part of an international team that discovered 61 additional genetic loci associated with stroke and six genes that are potential targets for drug therapy to prevent or treat stroke.
October 3, 2022
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found.
